Zhao Yuping

Specializes in the diagnosis and treatment of various basic surgical diseases; particularly skilled in the surgical diagnosis and treatment of pancreatic, biliary, gastrointestinal, and thyroid diseases, especially pancreatic diseases. With over forty years of medical experience, he has worked on the front lines of clinical practice, research, and teaching in general surgery, conducting comprehensive basic and clinical research on pancreatic cancer and achieving systematic and pioneering results. He proposed the concept of "high-risk groups for pancreatic cancer," proposed and established a "green channel for pancreatic cancer diagnosis and treatment," and pioneered the establishment of a pancreatic disease consultation center in China, enabling patients to receive the best treatment plan as early as possible through a multidisciplinary team (MDT) model. He pioneered the transjejunostomy technique, successfully performed China's first laparoscopic insulinoma resection, and was the first in China to perform robotic insulinoma surgery. He led the development of the Chinese Medical Association's guidelines for the diagnosis and treatment of pancreatic cancer and the Ministry of Health's national industry standards for the diagnosis and treatment of pancreatic cancer. He has undertaken more than 20 national and provincial-level research projects, published over 300 papers, and received the second prize of the National Science and Technology Progress Award, the first prize of the Chinese Medical Science and Technology Progress Award, and the Ho Leung Ho Lee Foundation Science and Technology Progress Award. He has received numerous honors, including the National May 1st Labor Medal, the Chinese Physician Award, the Outstanding Young and Middle-aged Expert of the Ministry of Health, the first Zhou Guangzhao Clinical Physician Award, and the Beijing Medical Ethics Model.